Trials / Unknown
UnknownNCT02687074
Effects of HFNC on Moderate and Severe Respiratory Failure Patients
Effects of High Flow Nasal Canula on Moderate and Severe Respiratory Failure Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 246 (estimated)
- Sponsor
- Southeast University, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Respiratory failure is the danger for the patients admitted in ICU, mechanical ventilation could save a lot of patients' life, however, it prolongs patients' ICU stay and hospital stay. High flow nasal cannula (HFNC) has advantages of PEEP effects, reducing dead space, increasing EELV and improving comfort, and it has been used to treat respiratory failure patients. In recent study, HFNC could improve mortality of respiratory failure patients with P/F\<200mmHg in the subgroup. The investigators want to start a randomized controlled study to evaluate the effects of HFNC on the patients with respiratory failure.
Detailed description
just as the brief summary
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HFNC | patients treated with high flow nasal cannula |
| DEVICE | NIV | patients treated with noninvasive ventilation |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-12-01
- Completion
- 2017-12-01
- First posted
- 2016-02-22
- Last updated
- 2016-02-22
Source: ClinicalTrials.gov record NCT02687074. Inclusion in this directory is not an endorsement.